MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

Search

Champions Oncology Inc

Open

BrancheGesundheitswesen

7.84 0.77

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

7.34

Max

7.92

Schlüsselkennzahlen

By Trading Economics

Einkommen

3.8M

4.5M

Verkäufe

3.6M

17M

KGV

Branchendurchschnitt

17.6

57.333

EPS

0.33

Gewinnspanne

26.381

Angestellte

210

EBITDA

3.8M

4.9M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+52.48% upside

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-25M

110M

Vorheriger Eröffnungskurs

7.07

Vorheriger Schlusskurs

7.84

Technischer Score

By Trading Central

Vertrauen

Weak Bearish Evidence

Champions Oncology Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

11. Dez. 2024, 23:55 UTC

Heiße Aktien

Stocks to Watch: Adobe, Champions Oncology, DBV Technologies

Peer-Vergleich

Kursveränderung

Champions Oncology Inc Prognose

Kursziel

By TipRanks

52.48% Vorteil

12-Monats-Prognose

Durchschnitt 12 USD  52.48%

Hoch 12 USD

Tief 12 USD

Basierend auf 1 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Champions Oncology Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

1 ratings

1

Buy

0

Halten

0

Sell

Technischer Score

By Trading Central

7.885 / 8.4328Unterstützung & Widerstand

Kurzfristig

Weak Bearish Evidence

Mittelfristig

Very Strong Bearish Evidence

Langfristig

Weak Bullish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Champions Oncology Inc

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.